BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang ZX, Li J, Wang EX, Xia DD, Bai W, Wang QH, Yuan J, Li XM, Niu J, Yin ZX, Xia JL, Fan DM, Han GH. Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization. World J Gastroenterol 2020; 26(15): 1805-1819 [PMID: 32351295 DOI: 10.3748/wjg.v26.i15.1805]
URL: https://www.wjgnet.com/1007-9327/full/v26/i15/1805.htm
Number Citing Articles
1
Zhongqi Sun, Zhongxing Shi, Yanjie Xin, Sheng Zhao, Hao Jiang, Jinping Li, Jiaping Li, Huijie Jiang. Contrast-Enhanced CT Imaging Features Combined with Clinical Factors to Predict the Efficacy and Prognosis for Transarterial Chemoembolization of Hepatocellular CarcinomaAcademic Radiology 2023; 30: S81 doi: 10.1016/j.acra.2022.12.031
2
Wei Zhang, Hui-Fang Kong, Xu-Dong Gao, Zheng Dong, Ying Lu, Jia-Gan Huang, Hong Li, Yong-Ping Yang. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinomaWorld Journal of Gastroenterology 2020; 26(35): 5287-5301 doi: 10.3748/wjg.v26.i35.5287
3
Ji Hoon Kim, Jin Hyoung Kim, Hyun-Ki Yoon, Gi-Young Ko, Ji Hoon Shin, Dong Il Gwon, Heung-Kyu Ko, Hee Ho Chu, Seong Ho Kim, Gun Ha Kim, Yonghun Kim, Shakir Aljerdah. Transarterial chemoembolization for advanced hepatocellular carcinoma without macrovascular invasion or extrahepatic metastasis: analysis of factors prognostic of clinical outcomesFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1072922
4
Apichat Kaewdech, Pimsiri Sripongpun, Natcha Cheewasereechon, Sawangpong Jandee, Naichaya Chamroonkul, Teerha Piratvisuth. Validation of the “Six-and-Twelve” Prognostic Score in Transarterial Chemoembolization–Treated Hepatocellular Carcinoma PatientsClinical and Translational Gastroenterology 2021; 12(2): e00310 doi: 10.14309/ctg.0000000000000310